Literature DB >> 33850181

Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering.

Kevin M Blum1,2, Lauren C Roby1,3, Jacob C Zbinden1,2, Yu-Chun Chang1,4, Gabriel J M Mirhaidari1,4, James W Reinhardt1, Tai Yi1, Jenny C Barker1,5, Christopher K Breuer6.   

Abstract

Tissue engineered vascular grafts hold promise for the creation of functional blood vessels from biodegradable scaffolds. Because the precise mechanisms regulating this process are still under investigation, inducible genetic mouse models are an important and widely used research tool. However, here we describe the importance of challenging the baseline assumption that tamoxifen is inert when used as a small molecule inducer in the context of cardiovascular tissue engineering. Employing a standard inferior vena cava vascular interposition graft model in C57BL/6 mice, we discovered differences in the immunologic response between control and tamoxifen-treated animals, including occlusion rate, macrophage infiltration and phenotype, the extent of foreign body giant cell development, and collagen deposition. Further, differences were noted between untreated males and females. Our findings demonstrate that the host-response to materials commonly used in cardiovascular tissue engineering is sex-specific and critically impacted by exposure to tamoxifen, necessitating careful model selection and interpretation of results.

Entities:  

Year:  2021        PMID: 33850181     DOI: 10.1038/s41598-021-87006-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  55 in total

Review 1.  Cardiac-specific inducible and conditional gene targeting in mice.

Authors:  Thomas Doetschman; Mohamad Azhar
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

2.  The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft.

Authors:  Ekene Onwuka; Cameron Best; Andrew Sawyer; Tai Yi; Eric Heuer; Malik Sams; Matthew Wiet; Hong Zheng; Themis Kyriakides; Christopher Breuer
Journal:  Regen Med       Date:  2017-05-19       Impact factor: 3.806

3.  Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure.

Authors:  Shaw-Yung Shai; Alice E Harpf; Christopher J Babbitt; Maria C Jordan; Michael C Fishbein; Ju Chen; Michelle Omura; Tarek A Leil; K David Becker; Meisheng Jiang; Desmond J Smith; Simon R Cherry; Joseph C Loftus; Robert S Ross
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

4.  Endoxifen, a new cornerstone of breast cancer therapy: demonstration of safety, tolerability, and systemic bioavailability in healthy human subjects.

Authors:  A Ahmad; S Shahabuddin; S Sheikh; P Kale; M Krishnappa; R C Rane; I Ahmad
Journal:  Clin Pharmacol Ther       Date:  2010-10-27       Impact factor: 6.875

5.  Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation.

Authors:  Seddik Hammad; Amnah Othman; Christoph Meyer; Ahmad Telfah; Joerg Lambert; Bedair Dewidar; Julia Werle; Zeribe Chike Nwosu; Abdo Mahli; Christof Dormann; Yan Gao; Kerry Gould; Mei Han; Xiaodong Yuan; Mikheil Gogiashvili; Roland Hergenröder; Claus Hellerbrand; Maria Thomas; Matthias Philip Ebert; Salah Amasheh; Jan G Hengstler; Steven Dooley
Journal:  Arch Toxicol       Date:  2018-07-04       Impact factor: 5.153

6.  Inducible Cre mice.

Authors:  Susanne Feil; Nadejda Valtcheva; Robert Feil
Journal:  Methods Mol Biol       Date:  2009

7.  Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomized female mice.

Authors:  Matthew J Hardman; Elaine Emmerson; Laura Campbell; Gillian S Ashcroft
Journal:  Endocrinology       Date:  2007-11-01       Impact factor: 4.736

8.  Late-term results of tissue-engineered vascular grafts in humans.

Authors:  Narutoshi Hibino; Edward McGillicuddy; Goki Matsumura; Yuki Ichihara; Yuji Naito; Christopher Breuer; Toshiharu Shinoka
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

9.  Low-dose tamoxifen treatment in juvenile males has long-term adverse effects on the reproductive system: implications for inducible transgenics.

Authors:  Saloni H Patel; Laura O'Hara; Nina Atanassova; Sarah E Smith; Michael K Curley; Diane Rebourcet; Annalucia L Darbey; Anne-Louise Gannon; Richard M Sharpe; Lee B Smith
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

10.  Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia.

Authors:  Hannah M Jahn; Carmen V Kasakow; Andreas Helfer; Julian Michely; Alexei Verkhratsky; Hans H Maurer; Anja Scheller; Frank Kirchhoff
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

View more
  4 in total

1.  Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism.

Authors:  Dino Šisl; Darja Flegar; Maša Filipović; Petra Turčić; Pavao Planinić; Alan Šućur; Nataša Kovačić; Danka Grčević; Tomislav Kelava
Journal:  Biomedicines       Date:  2022-05-23

Review 2.  Fibrocytes: A Critical Review and Practical Guide.

Authors:  James W Reinhardt; Christopher K Breuer
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 3.  Animal studies for the evaluation of in situ tissue-engineered vascular grafts - a systematic review, evidence map, and meta-analysis.

Authors:  Suzanne E Koch; Bente J de Kort; Noud Holshuijsen; Hannah F M Brouwer; Dewy C van der Valk; Patricia Y W Dankers; Judith A K R van Luijk; Carlijn R Hooijmans; Rob B M de Vries; Carlijn V C Bouten; Anthal I P M Smits
Journal:  NPJ Regen Med       Date:  2022-02-23

4.  Tamoxifen reduces silicone implant capsule formation in a mouse model.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Jacob C Zbinden; Christopher K Breuer; Jenny C Barker
Journal:  FASEB Bioadv       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.